Literature DB >> 30352197

Reclassifying Idiopathic Uveitis: Lessons From a Tertiary Uveitis Center.

Rene Y Choi1, Erick Rivera-Grana1, James T Rosenbaum2.   

Abstract

PURPOSE: Idiopathic uveitis is frequently the most common diagnosis in series from uveitis clinics. This study sought to determine the percentage of patients initially diagnosed as idiopathic, noninfectious uveitis referred to a tertiary uveitis center who were subsequently found to have an identifiable cause of uveitis.
DESIGN: Retrospective case series.
METHODS: We performed a computerized database analysis of 179 consecutive patients who were referred to our practice with the diagnosis of idiopathic, noninfectious uveitis between 2008 and 2016. Patients were evaluated by a thorough history and ophthalmic examination with selected laboratory testing targeted by clues from the history and examination. Standardization of Uveitis Nomenclature (SUN) criteria were used to better assess different types of uveitis.
RESULTS: Fifty-two out of 179 (29.0%) patients initially diagnosed with idiopathic uveitis were subsequently diagnosed with an underlying condition. Among patients referred with a diagnosis of idiopathic disease, female patients were most commonly affected (121/179; 67.6%). Among subsequent diagnoses, sarcoidosis was the most common (19/52 or 36.5%), followed by HLA-B27-associated uveitis (11/52, 21.1%), infectious uveitis (6/52, 11.5%), tubulointerstitial nephritis with uveitis (6/52, 11.5%), and juvenile idiopathic uveitis (4/52, 7.7%). Other diagnosable conditions included Behçet disease, multifocal choroiditis, panuveitis, Crohn disease, multiple sclerosis, and relapsing polychondritis. An underlying condition was not found in 127 of 179 (70.9%) patients.
CONCLUSIONS: We report that 29% of patients referred to our tertiary uveitis center diagnosed as "idiopathic" had an associated identifiable cause. Identifying an underlying condition associated with uveitis could be potentially lifesaving for some illnesses (eg, sarcoidosis with cardiac involvement) and is critical to management (eg, infection). Although we were able to use limited testing to classify many patients who had been previously incorrectly labeled with idiopathic uveitis, idiopathic uveitis remains the most common diagnosis in our uveitis clinic.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30352197      PMCID: PMC6349540          DOI: 10.1016/j.ajo.2018.10.018

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  32 in total

1.  Distinguishing Uveitis Secondary to Sarcoidosis From Idiopathic Disease: Cardiac Implications.

Authors:  Yong Seop Han; Erick Rivera-Grana; Sherveen Salek; James T Rosenbaum
Journal:  JAMA Ophthalmol       Date:  2018-02-01       Impact factor: 7.389

2.  Enhanced recognition, treatment, and prognosis of tubulointerstitial nephritis and uveitis syndrome.

Authors:  Friederike Mackensen; Justine R Smith; James T Rosenbaum
Journal:  Ophthalmology       Date:  2007-03-26       Impact factor: 12.079

Review 3.  New developments in uveitis associated with HLA B27.

Authors:  James T Rosenbaum
Journal:  Curr Opin Rheumatol       Date:  2017-07       Impact factor: 5.006

4.  Chest computerized tomography in the evaluation of uveitis in elderly women.

Authors:  Peter K Kaiser; Careen Y Lowder; Preston Sullivan; Steven R Sanislo; Gregory S Kosmorsky; Moulay A Meziane; Thomas W Rice; Scott D Smith; David M Meisler
Journal:  Am J Ophthalmol       Date:  2002-04       Impact factor: 5.258

5.  Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial.

Authors:  Quan Dong Nguyen; Pauline T Merrill; Glenn J Jaffe; Andrew D Dick; Shree Kumar Kurup; John Sheppard; Ariel Schlaen; Carlos Pavesio; Luca Cimino; Joachim Van Calster; Anne A Camez; Nisha V Kwatra; Alexandra P Song; Martina Kron; Samir Tari; Antoine P Brézin
Journal:  Lancet       Date:  2016-08-16       Impact factor: 79.321

6.  Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis.

Authors:  Thomas W Harper; Darlene Miller; Joyce C Schiffman; Janet L Davis
Journal:  Am J Ophthalmol       Date:  2008-10-02       Impact factor: 5.258

Review 7.  Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease.

Authors:  James T Rosenbaum
Journal:  Clin Rheumatol       Date:  2015-05-08       Impact factor: 2.980

8.  Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial.

Authors:  J Braun; J Brandt; J Listing; A Zink; R Alten; G Burmester; W Golder; E Gromnica-Ihle; H Kellner; M Schneider; H Sörensen; H Zeidler; J Reddig; J Sieper
Journal:  Arthritis Rheum       Date:  2003-08

Review 9.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

10.  The association of human leukocyte antigen B27 with anterior uveitis in patients from the western region of Saudi Arabia: a retrospective study.

Authors:  Ahmed M Bawazeer; Heba Ismail Joharjy
Journal:  Clin Ophthalmol       Date:  2013-10-30
View more
  6 in total

1.  C-reactive protein/albumin ratio as an indicator of disease activity in Behçet's disease and human leukocyte antigen-B27-associated uveitis.

Authors:  Mirinae Kim; Young-Gun Park; Young-Hoon Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-04-30       Impact factor: 3.117

2.  Ocular sarcoidosis prevalence and clinical features in the Northern Ireland population.

Authors:  Gerard Reid; Michael Williams; Marie Compton; Giuliana Silvestri; Clara McAvoy
Journal:  Eye (Lond)       Date:  2021-09-23       Impact factor: 4.456

3.  Characteristics, evolution, and outcome of patients with non-infectious uveitis referred for rheumatologic assessment and management: an Egyptian multicenter retrospective study.

Authors:  Waleed A Hassan; Basma M Medhat; Maha M Youssef; Yomna Farag; Noha Mostafa; Alshaimaa R Alnaggar; Mervat E Behiry; Rasha A Abdel Noor; Riham S H M Allam
Journal:  Clin Rheumatol       Date:  2020-09-02       Impact factor: 2.980

4.  Revising the Diagnosis of Idiopathic Uveitis by Peripheral Blood Transcriptomics.

Authors:  James T Rosenbaum; Christina A Harrington; Robert P Searles; Suzanne S Fei; Amr Zaki; Sruthi Arepalli; Michael A Paley; Lynn M Hassman; Albert T Vitale; Christopher D Conrady; Puthyda Keath; Claire Mitchell; Lindsey Watson; Stephen R Planck; Tammy M Martin; Dongseok Choi
Journal:  Am J Ophthalmol       Date:  2020-09-15       Impact factor: 5.258

Review 5.  Pediatric uveitis: Role of the pediatrician.

Authors:  Abhay Shivpuri; Inga Turtsevich; Ameenat Lola Solebo; Sandrine Compeyrot-Lacassagne
Journal:  Front Pediatr       Date:  2022-08-01       Impact factor: 3.569

6.  Demography and clinical pattern of newly diagnosed uveitis patients in Malaysia.

Authors:  Rajasudha Sawri Rajan; Shelina Oli Mohamed; Mohamad Aziz Salowi
Journal:  J Ophthalmic Inflamm Infect       Date:  2022-09-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.